FDA Inspection
HomeChoice Partners dba BioScript Infusion ServicesHomeChoice Partners dba BioScript Infusion Services – FDA Inspection, Aug 17, 2018
Record Details
This FDA Inspection record concerns HomeChoice Partners dba BioScript Infusion Services, with an inspection on August 17, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- August 17, 2018
- Product Type
- Drugs
View Company Profile
ID · b167f834-d345-4fa2-8d54-b63f004a7e30
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1063039
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
Full citation text and observation details available on the Dashboard.
Other FDA inspections of HomeChoice Partners dba BioScript Infusion Services
1| Date | Classification | Office | Project area |
|---|---|---|---|
| August 9, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for HomeChoice Partners dba BioScript Infusion Services
- FDA Inspection 1149010 - 2021-08-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.